PharmaEssentia (LUX:PHECR) Cyclically Adjusted FCF per Share: $0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LUX:PHECR PharmaEssentia Corp LUX:PHECR
76 GF Score
Price $16.40
GF Value $7.31
! 5 Warning Signs
View Full Analysis

What is PharmaEssentia Cyclically Adjusted FCF per Share?

PharmaEssentia LUX:PHECR 76 Cyclically Adjusted FCF per Share is $0.00 as of Jun. 2026. GuruFocus rates LUX:PHECR with a GF Score™ of 76/100 and a GF Value™ of $7.31. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

PharmaEssentia's adjusted free cash flow per share for the three months ended in Jun. 2026 was $0.139. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.00 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-08-19), PharmaEssentia's current stock price is $16.3964. PharmaEssentia's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was $0.00. PharmaEssentia's Cyclically Adjusted Price-to-FCF of today is .


PharmaEssentia  (LUX:PHECR) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


PharmaEssentia Cyclically Adjusted FCF per Share Related Terms


PharmaEssentia Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for PharmaEssentia's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaEssentia Cyclically Adjusted FCF per Share Chart

PharmaEssentia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.10 -0.07 -0.07

PharmaEssentia Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.07 -0.07 -0.05 0.00

LUX:PHECR vs ZTS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PharmaEssentia's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaEssentia Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PharmaEssentia's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where PharmaEssentia's Cyclically Adjusted Price-to-FCF falls into.


LUX:PHECR
76GF Score
PharmaEssentia Corp LUX:PHECR
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaEssentia Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PharmaEssentia's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.139/333.9520*333.9520
=0.139

Current CPI (Jun. 2026) = 333.9520.

PharmaEssentia Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 -0.018 241.428 -0.025
201612 -0.019 241.432 -0.026
201703 -0.028 243.801 -0.038
201706 -0.027 244.955 -0.037
201709 -0.018 246.819 -0.024
201712 -0.026 246.524 -0.035
201803 -0.025 249.554 -0.033
201806 -0.030 251.989 -0.040
201809 -0.032 252.439 -0.042
201812 -0.029 251.233 -0.039
201903 -0.034 254.202 -0.045
201906 -0.033 256.143 -0.043
201909 -0.017 256.759 -0.022
201912 -0.049 256.974 -0.064
202003 -0.026 258.115 -0.034
202006 -0.031 257.797 -0.040
202009 -0.039 260.280 -0.050
202012 -0.089 260.474 -0.114
202103 -0.084 264.877 -0.106
202106 -0.077 271.696 -0.095
202109 -0.060 274.310 -0.073
202112 -0.060 278.802 -0.072
202203 -0.090 287.504 -0.105
202206 -0.025 296.311 -0.028
202209 -0.018 296.808 -0.020
202212 -0.050 296.797 -0.056
202303 -0.092 301.836 -0.102
202306 -0.041 305.109 -0.045
202309 0.022 307.789 0.024
202312 -0.058 306.746 -0.063
202403 -0.034 312.332 -0.036
202406 0.059 314.175 0.063
202409 0.063 315.301 0.067
202412 0.036 315.605 0.038
202503 0.062 319.799 0.065
202506 -0.018 322.561 -0.019
202509 0.151 324.800 0.155
202512 0.068 324.054 0.070
202603 0.088 330.213 0.089
202606 0.139 333.952 0.139

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.00 mean?
PharmaEssentia (LUX:PHECR) has a Cyclically Adjusted FCF per Share of $0.00 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on PharmaEssentia and its competitors.
Is PharmaEssentia's Cyclically Adjusted FCF per Share too high?
PharmaEssentia's current Cyclically Adjusted FCF per Share is $0.00. Overall, PharmaEssentia has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does PharmaEssentia's Cyclically Adjusted FCF per Share compare to ZTS?
PharmaEssentia's Cyclically Adjusted FCF per Share of $0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on PharmaEssentia and its competitors. PharmaEssentia's current Cyclically Adjusted FCF per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaEssentia stock overvalued right now?
PharmaEssentia (LUX:PHECR) has a current Cyclically Adjusted FCF per Share of $0.00. The stock's GF Value™ is $7.31, compared to a current price of $16.40 — trading 124.3% above its estimated fair value. The current Cyclically Adjusted FCF per Share is $0.00. PharmaEssentia's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For PharmaEssentia (LUX:PHECR), the current Cyclically Adjusted FCF per Share is $0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PharmaEssentia (LUX:PHECR) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaEssentia stock appears to be overvalued. The current stock price of $16.40 is trading 124.3% above its estimated GF Value™ of $7.31.

Key valuation signals for LUX:PHECR:

  • Cyclically Adjusted FCF per Share: $0.00
  • GF Value™: $7.31 vs. price of $16.40 (124.3% above fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the LUX:PHECR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PharmaEssentia Business Description

Other Exchanges 6446:Taiwan
Address 13th Floor, No.3, Park Street, Nangang District, Taipei, TWN, 115
PharmaEssentia Corp engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API and new drug patterns developments. Its products include BESREMi, Ropeginterferon alfa-2b, Ropeg + anti PD-1, PEG-IL-2, PEG-Cytokines, PD-1-IL-2v, NY-ESO-1 TCR-T, among others. It derives revenue from medicine products sales from contracts with customers.
76GF Score

Get the complete analysis for LUX:PHECR

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.40
Price
$7.31
GF Value